Without using animals: antibodies from algae for pregnancy tests

Start-up develops new process - DBU provides funding

19-Nov-2024 - It is not every day that young start-ups from Germany launch an innovation with industry-changing potential onto the market. But this is exactly what Phaeosynt, a company founded out of the University of Hanover, is planning to do with its diatom-derived antibodies for medical diagnostics. Until ...

Enhancing at-home COVID tests with glow-in-the dark materials

09-Mar-2023 - Researchers at the University of Houston are using glow-in-the-dark materials to enhance and improve rapid COVID-19 home tests. If you’ve taken an at-home COVID-19 or pregnancy test, then you’ve taken what is scientifically called a lateral flow assay (LFA) test, a diagnostic tool widely used ...

Highly potent and stable nanobodies stop SARS-CoV-2

Alpacas provide blueprints for mini-antibodies

30-Jul-2021 - A team of researchers has developed mini-antibodies that efficiently eliminate the SARS-CoV-2 coronavirus and its dangerous new variants. The so-called nanobodies bind and neutralize the virus up to 1000 times better than previously developed mini-antibodies. In addition, the researchers were ...

New separation technology for biomolecules

i3 Membrane receives 7 figure sum for development and market launch

26-Jan-2021 - Four investors are financing the further growth of i3 Membrane GmbH. High-tech venture capital investor HTGF from Bonn, Germany, and three private investors are together investing a 7 figure sum in the further development and market launch of new separation technology for biological molecules. ...

Antibodies to a retina protein to be used as a kidney cancer marker

Suggestion of new method for diagnosing kidney cancer

22-Jan-2019 - Sechenov University together with their German colleagues suggest a new highly sensitive, quick, and pain-free method for diagnosing kidney cancer. This method is based on measuring of the immune response to arrestin-1, a retina protein that is synthesized in the cancerous cells of ...

A 3D structure of 1918 influenza virus-like particles

16-Jul-2018 - Virus-like particles (VLPs) are protein-based structures that mimic viruses and bind to antibodies. Because VLPs are not infectious, they show considerable promise as vaccine platforms for many viral diseases, including influenza. Realizing that fine details about influenza VLPs were scant, a ...

Therapeutic Antibodies Show Variations

Subtle Differences: Therapeutic Antibodies Vary Depending on Production System

11-Jul-2018 - Differences in production methods for therapeutic antibodies can lead to variations in their structure, depending on the recombinant procedure selected. The distinctions, which are based on a number of glycosylations, even impact antibodies’ stability. This was the result of a high-precision ...

Aptamer Group raises $2.2M investment

02-Jul-2018 - Rapidly growing biotech business,Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from overseas investors to support its pioneering aptamer development programme. The funding will enable the expansion of the York ...

Cancer: Tumor transition states

23-Apr-2018 - Researchers at the Université libre de Bruxelles, ULB define for the first time the tumor transition states occurring during cancer progression and identify the tumor cell populations responsible for metastasis. Tumor heterogeneity describes the differences between different cells within a given ...

Study of COPD patients has created a 'looking glass' into genome of pathogen

21-Mar-2018 - Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does the most harm to patients. The results provide the first insights into how ...